SCYNEXIS INC — Director's Dealing 2019

Feb 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2019-02-15

Reporting Person: Angulo Gonzalez David (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-15	Common Stock	A	150000	$0.00	Acquired	271790	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-15	Stock Option (Right to Buy)	$1.38	A	150000	Acquired	2029-02-14	Common Stock (150000)	Direct

Footnotes

F1: Represents restricted stock units that vest 25% per year over four years.

F2: 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.